Breast augmentation, mastopexy, and reduction each produce incision patterns that do not behave the same way. The periareolar incision sits on a curved border under circumferential tension. The inframammary fold incision sustains gravitational load throughout recovery. The vertical segment, present in most lift and reduction patterns, bridges two tension environments and moves with every shift in posture. These are not interchangeable scar locations, and they do not respond identically to the same silicone format. A single sheet cut from a standard roll conforms adequately to one geometry and poorly to another. The Silagen Breast Kit Clear was developed to address that clinical reality: it pairs pre-shaped breast silicone sheets with a medical-grade silicone gel so that each incision segment receives the format that actually contacts and maintains the tissue interface it needs.
Quick Answer
What it is: The Silagen Breast Kit Clear is a medical-grade silicone combination kit containing pre-shaped breast sheets and silicone gel, designed for multi-incision scar management after breast surgery.
When to start: After full epithelialization of all incision lines. In most patients this is two to three weeks post-suture removal, once every segment is closed, dry, and scab-free. Do not begin if any portion of any incision line remains open.
How long to use: Eight to twelve weeks minimum. Patients with hypertrophic scar history, high gravitational tension across the inframammary segment, or Fitzpatrick skin types IV through VI should plan for up to six months of consistent use.
Who it is for: Patients following breast augmentation, mastopexy, breast reduction, or any procedure that produces periareolar and inframammary incisions simultaneously.
Why the Kit Format Solves a Problem Single-Format Silicone Cannot
Silicone sheets adhere reliably to flat and gently curved surfaces. They perform well on the inframammary fold when the skin lies relatively flat and the sheet can maintain full contact across its surface. The periareolar border is a different geometry. It is a tight convex curve, and a sheet sized and shaped for the fold will tent, lift, and lose contact at the edges when applied to the areolar border. Partial contact reduces occlusion and diminishes the silicone effect at exactly the site where consistent coverage matters.
Silicone gel resolves that problem. Gel conforms to any surface contour, fills irregular borders, and maintains the semi-occlusive interface on curved or concave surfaces where sheet adhesion is physically inconsistent. In the Breast Kit Clear, the sheets handle the inframammary fold and any accessible flat segments of the vertical limb. The gel covers the periareolar border, fills gaps during activity or showering when sheets are removed, and extends daily coverage hours during periods when sheets cannot be worn. The two components are not redundant. Each addresses the segment the other cannot serve reliably.
How Silicone Works at the Tissue Level
The mechanism behind silicone scar therapy is not moisture alone. Silicone sheeting and gel reduce transepidermal water loss (TEWL) across the scar surface by creating a semi-occlusive microenvironment. Under reduced TEWL, fibroblast activity at the wound site downregulates. Fibroblasts are the cells responsible for collagen synthesis during the remodeling phase of wound healing. When their activity is modulated by a stable, low-TEWL environment, the ratio of collagen type III to collagen type I shifts toward a pattern that produces softer, flatter, less raised scar tissue. This is the mechanism that separates silicone from topical cosmetic products that work only at the epidermal surface.
Breast surgery introduces a specific risk factor that elevates hypertrophic scar formation at the inframammary segment: gravitational tension. The inframammary fold bears the continuous downward pull of breast tissue weight throughout the recovery period. That sustained tension at the wound interface increases fibroblast recruitment and collagen deposition beyond what would occur in a non-weight-bearing scar. Early and consistent silicone therapy at that location is not optional for patients at elevated risk. It is the standard of care.
Mustoe et al. established the international clinical consensus on silicone as first-line prophylactic scar therapy. Gold et al. confirmed that topical silicone applied prophylactically following surgical procedures reduces hypertrophic scar formation in a controlled office-based population. For patients with Fitzpatrick skin types IV through VI, prophylactic silicone therapy is indicated from the earliest point of wound closure, as these patients carry substantially elevated risk for hypertrophic and keloidal outcomes at all incision sites, including the inframammary fold.
Dr. Nazarian's Clinical Protocol
|
What I See at Follow-Up
At two weeks, most patients have achieved stable closure across all segments and can tolerate full sheet and gel coverage. The inframammary fold is the most common site of incomplete closure at this visit, particularly in reduction patients where the T-junction convergence adds tissue stress at the lower pole. I do not rush the start date at that location.
At six weeks, the periareolar border typically shows earlier softening than the inframammary fold. Patients who have maintained twenty or more hours of daily silicone contact show measurably less erythema and earlier flattening than those with inconsistent protocols. The inframammary segment in patients who had submuscular augmentation combined with a lift often shows the most persistent tension response at this visit. I extend their protocol to the full six months without exception.
At twelve weeks, patients with consistent protocol adherence across all segments present with scars that are substantially flatter, paler, and more pliable than the six-week baseline. The inframammary fold remains the last segment to reach cosmetic maturity in nearly every case, and I counsel patients at the start of treatment that this is anatomically expected, not a failure of the product or their compliance.
The Silagen Breast Kit Clear is available at The Skin Spot — physician-verified and guaranteed authentic.
Frequently Asked Questions
When can I start silicone therapy after breast surgery?
I clear patients to begin silicone therapy once every incision segment is fully epithelialized, dry, and scab-free. For most patients this is two to three weeks after suture removal. The critical factor is that no portion of any incision line is open or crusting. Starting silicone on incomplete closure traps bacteria and delays healing. If your inframammary fold and periareolar border close at different rates, start coverage only on the segments that are fully closed and add the remaining segments when they are ready.
How do I use the sheet and the gel together in the same day?
I instruct patients to apply the sheets during the longest continuous dry period of their day, typically overnight and through morning hours, and to switch to gel during showering, exercise, or any period when sheets are removed. The goal is twenty or more combined hours of silicone contact across all incision segments per day. The two formats are not interchangeable at every location. Sheets go on flat and accessible surfaces. Gel goes on the periareolar border and fills any gap where sheet adhesion is unreliable.
Can I use the Breast Kit Clear after breast augmentation, or is it only for reduction and lift?
The kit is appropriate for any procedure that produces periareolar or inframammary incisions, including augmentation with a periareolar or inframammary approach, mastopexy, and reduction. Augmentation patients without a vertical segment still benefit from the combination format because the periareolar border and inframammary fold respond differently to the same sheet geometry. The clinical argument for the kit applies to augmentation patients as directly as it applies to lift or reduction patients.
How is this different from using a standard silicone sheet on its own?
A standard sheet cut to fit a breast incision pattern will conform well to whichever segment it was shaped for and poorly to the others. The inframammary fold is a different surface geometry than the periareolar border. A sheet optimized for the fold will lift and lose contact at the areolar curve. The gel component in the kit solves that problem. The kit is a format solution for the multi-incision reality of breast surgery, not a larger version of a single-format product.
What do I do if the sheet lifts at the inframammary fold?
Lifting at the inframammary fold is typically caused by moisture accumulation under the sheet from skin movement or sweat, or by insufficient skin preparation before application. Make sure the skin is clean and fully dry before applying. In patients whose inframammary fold remains consistently difficult for sheet adhesion, I have them apply gel at that segment rather than forcing sheet contact that will not hold. Consistent gel coverage at a reliable contact depth is more effective than intermittent sheet coverage that lifts and breaks the occlusive seal.
Explore the Full Silagen Line
The Breast Kit Clear is part of a complete clinical scar management system. Additional formats are available for every incision geometry and recovery phase:
-
Silagen Collection: the full range of medical-grade silicone scar products
-
Scar Reduction Collection: targeted products for established and post-surgical scars
-
Surgical Recovery Collection: recovery-phase products curated for post-operative patients
The Silagen Breast Kit Clear is available directly through The Skin Spot. Patients with scar-specific questions can reach our team at Contact Us.
Clinical References
Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-571.
Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 2001;27(7):641-644.
Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009;80(3):253-260.
About the Author
Dr. Sheila Nazarian is a board-certified plastic and reconstructive surgeon based in Beverly Hills and the founder of Nazarian Plastic Surgery, Spa26, and The Skin Spot. She holds an appointment as Assistant Professor in the Division of Plastic Surgery at the University of Southern California and is the star of the Emmy-nominated Netflix series Skin Decision: Before and After. Dr. Nazarian performs breast augmentation, mastopexy, and reduction as a core component of her surgical practice and has guided hundreds of patients through multi-incision recovery protocols. The scar management guidance in this article reflects the clinical standards she applies in her own post-operative care.